A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes

Habib Yaribeygi, Stephen Atkin, Matteo Pirro, Amirhossein Sahebkar

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The global prevalence of Type 2 diabetes mellitus and its associated complications are growing rapidly. Although the role of hyperglycemia is well recognized in the pathophysiology of diabetic complications, its exact underlying mechanisms are not fully understood. In this regard, accumulating evidence suggests that the role of inflammation appears pivotal, with studies showing that most diabetic complications are associated with an inflammatory response. Several classes of antidiabetic agents have been introduced for controlling glycemia, with evidence that these pharmacological agents may have modulatory effects on inflammation beyond their glucose-lowering activity. Here we review the latest evidence on the anti-inflammatory effects of commonly used antidiabetic medications and discuss the relevance of these effects on preventing diabetic complications.

Original languageEnglish
JournalJournal of Cellular Physiology
DOIs
Publication statusAccepted/In press - 1 Jan 2018

Fingerprint

Diabetes Complications
Medical problems
Hypoglycemic Agents
Blood Vessels
Anti-Inflammatory Agents
Inflammation
Glucose
Hyperglycemia
Type 2 Diabetes Mellitus
Pharmacology

Keywords

  • cytokine
  • diabetes mellitus (DM)
  • diabetic complications
  • diabetic nephropathy (DN)
  • hypoglycemic agents
  • inflammation
  • tumor necrosis factor α (TNF-α)

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Cell Biology

Cite this

A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes. / Yaribeygi, Habib; Atkin, Stephen; Pirro, Matteo; Sahebkar, Amirhossein.

In: Journal of Cellular Physiology, 01.01.2018.

Research output: Contribution to journalArticle

@article{04196e7d4c45416dbaa13a507f9f7b6b,
title = "A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes",
abstract = "The global prevalence of Type 2 diabetes mellitus and its associated complications are growing rapidly. Although the role of hyperglycemia is well recognized in the pathophysiology of diabetic complications, its exact underlying mechanisms are not fully understood. In this regard, accumulating evidence suggests that the role of inflammation appears pivotal, with studies showing that most diabetic complications are associated with an inflammatory response. Several classes of antidiabetic agents have been introduced for controlling glycemia, with evidence that these pharmacological agents may have modulatory effects on inflammation beyond their glucose-lowering activity. Here we review the latest evidence on the anti-inflammatory effects of commonly used antidiabetic medications and discuss the relevance of these effects on preventing diabetic complications.",
keywords = "cytokine, diabetes mellitus (DM), diabetic complications, diabetic nephropathy (DN), hypoglycemic agents, inflammation, tumor necrosis factor α (TNF-α)",
author = "Habib Yaribeygi and Stephen Atkin and Matteo Pirro and Amirhossein Sahebkar",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/jcp.27699",
language = "English",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes

AU - Yaribeygi, Habib

AU - Atkin, Stephen

AU - Pirro, Matteo

AU - Sahebkar, Amirhossein

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The global prevalence of Type 2 diabetes mellitus and its associated complications are growing rapidly. Although the role of hyperglycemia is well recognized in the pathophysiology of diabetic complications, its exact underlying mechanisms are not fully understood. In this regard, accumulating evidence suggests that the role of inflammation appears pivotal, with studies showing that most diabetic complications are associated with an inflammatory response. Several classes of antidiabetic agents have been introduced for controlling glycemia, with evidence that these pharmacological agents may have modulatory effects on inflammation beyond their glucose-lowering activity. Here we review the latest evidence on the anti-inflammatory effects of commonly used antidiabetic medications and discuss the relevance of these effects on preventing diabetic complications.

AB - The global prevalence of Type 2 diabetes mellitus and its associated complications are growing rapidly. Although the role of hyperglycemia is well recognized in the pathophysiology of diabetic complications, its exact underlying mechanisms are not fully understood. In this regard, accumulating evidence suggests that the role of inflammation appears pivotal, with studies showing that most diabetic complications are associated with an inflammatory response. Several classes of antidiabetic agents have been introduced for controlling glycemia, with evidence that these pharmacological agents may have modulatory effects on inflammation beyond their glucose-lowering activity. Here we review the latest evidence on the anti-inflammatory effects of commonly used antidiabetic medications and discuss the relevance of these effects on preventing diabetic complications.

KW - cytokine

KW - diabetes mellitus (DM)

KW - diabetic complications

KW - diabetic nephropathy (DN)

KW - hypoglycemic agents

KW - inflammation

KW - tumor necrosis factor α (TNF-α)

UR - http://www.scopus.com/inward/record.url?scp=85056347886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056347886&partnerID=8YFLogxK

U2 - 10.1002/jcp.27699

DO - 10.1002/jcp.27699

M3 - Article

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

ER -